This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Memorial Hospital for Cancer and Allied Diseases, Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for Cancer Research. Active years: 2026.
Company Filing History:
1 out of 24 
1 out of 615 
1 out of 517 
Years Active: 2026
Title: Morgan Huse: Innovator in Cancer Immunotherapy
Introduction
Morgan Huse is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer immunotherapy, particularly through his innovative patent. His work focuses on enhancing the immune system's ability to combat tumors, which is crucial in the ongoing fight against cancer.
Latest Patents
Morgan Huse holds a patent titled "MIR200C-EPCAM AXIS REPROGRAMMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION." This patent represents a breakthrough in the development of reprogrammed immune cells that can more effectively target and destroy cancer cells. His innovative approach has the potential to improve treatment outcomes for patients suffering from various types of cancer. He has 1 patent to his name.
Career Highlights
Throughout his career, Morgan has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and Allied Diseases. His experience in these leading cancer research facilities has allowed him to collaborate with some of the brightest minds in the field, further enhancing his contributions to cancer treatment.
Collaborations
One of his notable collaborators is Minggang Zhang. Their partnership has fostered advancements in cancer research and has contributed to the development of innovative therapeutic strategies.
Conclusion
Morgan Huse is a dedicated inventor whose work in cancer immunotherapy is paving the way for new treatment options. His patent and collaborations highlight his commitment to improving patient outcomes in the fight against cancer.